Venture Cup Startup

Flemingsberg Science Award STARTUP open for contestants

STARTUP is a competition for startups with a clear connection to Flemingsberg, either as students, residents or otherwise active in the area.

In addition to the prize money of SEK 10,000, the winner will also have a free place for three months in Flemingsbergs Sciences’ innovation environment. Deadline for participation is April 5.

All ideas are welcome to participate in STARTUP as long as you compete with your own idea and the turnover and external equity is below SEK 1,000,000 at the time you submit to the competition. After that, we of course welcome you to continue working with the business idea, sales and any investments.

More information and registration.

The Flemingsberg Science Award is a sub-competition to the national business plan competition Venture Cup. Venture Cup was launched in 1998 to support growth in Sweden. Since then, the concept has grown to include a successful process where participants receive help to develop their business ideas for tomorrow’s companies. Knowledgeable industry experts engage non-profit by providing feedback and development tips on all ideas submitted. In addition, the organization offers inspiration, training, guidance and the opportunity to create a solid network.

Read more about Venture Cup

Cellaviva: improving lives through stem cell technology

“Cellaviva was founded by researchers from Karolinska Institutet, in the belief that stem cells will revolutionize how complex and incurable diseases are treated. We are a biobank that helps expectant parents to save stem cells from the umbilical cord at birth, in a so-called family bank. The aim is to make high-quality, potent cells available quickly, if medical needs arise. This creates treatment opportunities and expands therapy options for the whole family,”

NextCell to treat type 1 diabetes in children with stem cells

NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2022-02-02T11:05:33+01:00
Go to Top